Schiffrin A, Guyda H, Robitaille P, Posner B
J Clin Endocrinol Metab. 1978 Mar;46(3):511-3. doi: 10.1210/jcem-46-3-511.
Plasma Somatomedin (SM) reactivity has been determined in patients with chronic renal failure and in normal children by radioreceptor assay (RRA) following acid gel filtration on Sephadex G-100. Total small molecular weight SM reactivity was obtained by the summation of all values between Kav 0.55 to 0.75. The mean SM reactivity (+/-SE) for the renal failure group (N = 9) was 154 +/- 10 ng/ml and for the normal subjects (N = 9) was 91 +/- 5 ng/ml (p less than .001). The renal failure group also had significantly increased mean levels of insulin, GH and PRL, but individual increases were not always concordant. Our data reveal that small molecular weight SM reactivity as determined by RRA of column eluates is increased in chronic renal failure compared to normal controls. Thus SM reactivity is not low in chronic renal failure, supporting the suggestion that peripheral antagonism to SM action contributes to the growth failure observed in these patients.
通过在Sephadex G - 100上进行酸性凝胶过滤后的放射受体分析(RRA),测定了慢性肾功能衰竭患者和正常儿童的血浆生长调节素(SM)反应性。通过将Kav 0.55至0.75之间的所有值相加,得到总小分子重量SM反应性。肾功能衰竭组(N = 9)的平均SM反应性(+/-SE)为154 +/- 10 ng/ml,正常受试者(N = 9)为91 +/- 5 ng/ml(p小于0.001)。肾功能衰竭组的胰岛素、生长激素(GH)和催乳素(PRL)平均水平也显著升高,但个体升高情况并不总是一致的。我们的数据显示,与正常对照组相比,慢性肾功能衰竭患者经柱洗脱液RRA测定的小分子重量SM反应性增加。因此,慢性肾功能衰竭患者的SM反应性并不低,这支持了以下观点:对SM作用的外周拮抗作用导致了这些患者出现生长障碍。